From: Jon Frederick (smiile@utkux.utcc.utk.edu)
Date: Wed Dec 24 1997 - 11:55:18 MST
ANNOUNCING MAPS-FORUM
The MAPS forum is the electronic discussion group of the Multidisciplinary
Association for Psychedelic Studies (MAPS). MAPS is a 501 (c) (3)
corporation chartered in 1986 as a membership-based research and
educational organization. Currently numbering 1400 members, MAPS focuses
on the development of beneficial, socially-sanctioned uses of psychedelic
drugs and marijuana. MAPS pursues its mission by helping scientific
researchers design, obtain governmental approval for, fund, conduct and
report on psychedelic research in human volunteers.
The MAPS forum supports this mission by allowing members to interact with
each other and with international experts in the psychedelic field. Topics
may include current news, book reviews, factual questions about
psychedelics or marijuana, psychedelics and marijuana in the media, ideas
for research and fundraising, and articles in the MAPS quarterly
bulletin/newsletter. Students who have written class papers on psychedelic
topics are encouraged to share their work here. M.D. and Ph.D.
researchers funded by MAPS are also asked to participate. The forum also
serves as a rapid response network when there are opportunities to
influence drug policy decisions that are critical to MAPS' mission.
Questions about anything MAPS is doing, or suggestions for anything MAPS
should be doing, are encouraged.
To maintain the high standards that members expect from MAPS, this is a
moderated list. Subscribers to maps-forum are assured of a high
signal/noise ratio. A maximum of five messages are selected for posting to
the list each day by the moderator. Although questions are welcome at all
levels of interest, the moderator prefers posted comments to be presented
at a level appropriate for a classroom or a professional meeting.
To subscribe to maps-forum, send email to majordomo@maps.org with
"subscribe maps-forum Albert Hofmann <youraddress>" (if your name is
Albert Hofmann) without the quotes, in the first line. Make sure
youraddress is enclosed within the <brackets> as shown. Leave the subject
line and all other lines blank. To unsubscribe, send email to
majordomo@maps.org with "unsubscribe maps-forum youraddress", without the
quotes, in the first line. Leave the subject line and all other lines
blank.
Subscriptions to maps-forum are free to MAPS members, and free to
non-members for a 90-day trial period. Memberships, which include a
subscription to the quarterly MAPS Bulletin, are available for
$35 (non-US: $50) for General Members, and $20 (non-US: $35) for
student/low income.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
For more information about MAPS, please visit the MAPS home page at
http://www.maps.org, featuring Bulletin back issues and the online
(keyword-searchable) psychedelic drug research bibliography.
MAPS
2121 Commonwealth Ave, Suite 220, Charlotte, NC 28205
Phone 704-334-1798 FAX 704-334-1799
for questions related to maps-forum, email: owner-maps-forum@maps.org
for all other questions, email: sylvia@maps.org
Albert Einstein wrote that "Imagination is more important than knowledge."
If you can even faintly imagine a cultural reintegration of the use of
psychedelics and the states of mind they engender, please consider joining
MAPS in supporting the expansion of scientific knowledge in this area.
Progress is possible with the support of individuals who care enough to
take individual and collective action.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
GUIDELINES FOR AUTHORS
(1) Questions are welcome at all levels of interest but posted comments
should be presented at a level appropriate for a classroom or a
professional meeting. Primarily, this means to assume a skeptical
audience. Make an effort to support your assertions with argumentation and
evidence. Clearly state the central point you are trying to make early in
your message. Provide definitions and/or examples when using unusual
terminology or advanced concepts. Make references to the literature and/or
URL's whenever possible.
(2) By the same token, please provide an introduction, summary, or
discussion of all references or URL's posted to the list. Don't just post
web addresses and say, "check this out."
(3) A maximum of five messages will be selected for posting to the list
each day. Short posts are prefered over longer posts. Consider breaking up
longer works into a series of installments over a week or several weeks.
If you have already received five messages from the forum in the past 24
hours, please wait until the next day to post.
(4) Persons who have not submitted recently will be given priority over
those who post to the list often. In general, it is prefered that
individual subscribers post no more often than once per week and only once
or twice per thread (although there are numerous exceptions). Consider
whether your response to a post is better sent to the author rather than
to the entire list.
(5) For purposes of legal safety, first person narratives confessing one's
own illegal drug use are always sent back to the author with a reminder of
this guideline.
(6) Relevant cross-posts from other sources are welcome (especially when
an introduction explaining the relevance is included), but original
content is prefered.
(7) General drug policy discussions (prohibition vs. legalization) are
not encouraged unless they specifically relate to research. Examples of
acceptable drug policy topics include: the influence of drug policy on
research, or the policy implications of research.
(8) When responding to a post on the list, *briefly* quote only the
relevant part of what you are specifically responding to, and write your
message under the quote.
This archive was generated by hypermail 2.1.5 : Fri Nov 01 2002 - 14:45:16 MST